---
schema_version: "secwatch.filing_event.v1"
accession: "0001157523-22-000502"
form_type: "8-K"
ticker: "ALDX"
cik: "0001341235"
company_name: "Aldeyra Therapeutics, Inc."
filed_at: "2022-04-28T23:59:59+00:00"
generated_at: "2026-06-26T03:15:50.920890+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aldeyra CFO Joshua Reed resigns; Bruce Greenberg named interim CFO

## Summary
- Joshua Reed resigns as CFO and Treasurer effective May 10, 2022, to pursue other opportunities.
- Bruce Greenberg, current VP and Controller, appointed Interim CFO and Treasurer.
- Greenberg has over 25 years of accounting experience; previously Corporate Controller at Karyopharm Therapeutics.
- Reed will assist transition and participate in Aldeyra's Q1 2022 earnings call.
- No disputes with management or board regarding Reed's resignation.

## SEC filing metadata
- accession: 0001157523-22-000502
- form_type: 8-K
- ticker: ALDX
- cik: 0001341235
- company_name: Aldeyra Therapeutics, Inc.
- filed_at: 2022-04-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/0001157523-22-000502-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/a52701292.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001157523-22-000502
- JSON: https://secwatch.observer/filing/0001157523-22-000502.json
- Plain text: https://secwatch.observer/filing/0001157523-22-000502.txt

## Key facts
- Executive change
  Joshua Reed resigned as Chief Financial Officer at Aldeyra Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On April 25, 2022, Joshua Reed notified Aldeyra Therapeutics, Inc. (the “Company”) of his intent to resign as the Company’s Chief Financial Officer and Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/0001157523-22-000502-index.htm
- Executive change
  Bruce Greenberg was appointed as Interim Chief Financial Officer at Aldeyra Therapeutics, Inc..
  - Action: appointed
  - Role: Interim Chief Financial Officer
  source text: Effective as of the Resignation Date, the Company plans to appoint Bruce Greenberg to serve as its Vice President of Finance, Interim Chief Financial Officer, and Treasurer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1341235/000115752322000502/0001157523-22-000502-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.